NEWSROOM Press Releases

    254 Results

    New Study Shows Biodesix’s VeriStrat Changes Treatment Decisions for Lung Cancer Patients; Reduces Over-Treatment at End of Life

    A new study published in Current Medical Research and Opinion shows that VeriStrat changes treatment decisions for patients with lung cancer.

    Biodesix® and Bioyong Announce Agreement for Joint Development and Commercialization of VeriStrat® Test in Greater China

    Biodesix and Bioyong announced a $38M deal for development and commercialization of VeriStrat in China.

    Clin-TOF Successfully Integrated into VeriStrat® Workflow

    Clin-TOF successfully integrated into VeriStrat® workflow

    Biodesix® Tests Demonstrate Ability to Stratify Patients Treated with Immunotherapy

    Biodesix presents data at the World Lung Conference showing the ability to stratify lung cancer patients treated with immunotherapy

    Blood-Based Diagnostic Assay Measures Immunotherapy Biomarker PD-L1

    Biodesix released data at ASCO-SITC on a new assay that measures PD-L1 in the blood of cancer patients.

    Study Results from Biodesix’s Immunotherapy Test Will Be Presented by Dr. Jeffrey Weber

    Dr. Jeffrey Weber will present study results of new Biodesix immunotherapy test at ITOC4

    Genestrat Liquid Biopsy Testing™ Now Includes ROS1 and RET Mutations

    Biodesix's GeneStrat liquid biopsy test now includes ROS1 and RET mutations. The test helps physicians make treatment decisions for cancer patients.

    Biodesix® and Progenetics Announce Distribution Agreement for Israel

    Biodesix and Progenetics have entered into an international agreement; Biodesix tests will be available in Israel for the first time.

    Biodesix to Present Study Data: Blood-Based Diagnostic Testing for PD-L1

    Biodesix will present data on blood-based diagnostic testing for PD-L1 at ASCO-SITC 2017; ddPCR test measuring mRNA expression from immune and cancer cells

    Biodesix Announces Data To Be Presented at AACR Annual Meeting 2017

    Biodesix will present data from three studies at AACR 2017 annual meeting, on genomic and proteomic assays.

    1 2 3 4 5 6 7 8 9